This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
Clinical trial NCT03349723 · COMPLETED
Trial details
- NCT number
- NCT03349723
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2018-03-05
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.